{"id":"https://openalex.org/A5114085878","orcid":"https://orcid.org/0009-0000-6420-1571","observed_orcids":["https://orcid.org/0009-0000-6420-1571"],"display_name":"Vicky Cheng","raw_author_names":["Vicky Cheng"],"full_name":"Vicky Cheng","works_count":6,"cited_by_count":8,"summary_stats":{"2yr_mean_citedness":1.75,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5114085878","orcid":"https://orcid.org/0009-0000-6420-1571","observed_orcids":["https://orcid.org/0009-0000-6420-1571"]},"affiliations":[{"institution":{"id":"https://openalex.org/I79619799","ror":"https://ror.org/03angcq70","display_name":"University of Birmingham","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]},"years":[2026,2025,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I79619799","ror":"https://ror.org/03angcq70","display_name":"University of Birmingham","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":3,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11819","display_name":"Data-Driven Disease Surveillance","count":2,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","count":1,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T13672","display_name":"Thomas Hardy Literature Studies","value":2.91e-05,"subfield":{"id":"https://openalex.org/subfields/1208","display_name":"Literature and Literary Theory"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11819","display_name":"Data-Driven Disease Surveillance","value":1.93e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":1.18e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","value":1.06e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11054","display_name":"Adrenal and Paraganglionic Tumors","value":6.3e-06,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9724640846252441},{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.5947999954223633},{"id":"177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","score":0.3968999981880188},{"id":"2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","score":0.3578999936580658},{"id":"2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","score":0.32499998807907104}],"counts_by_year":[{"year":2019,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2021,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":3},{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":5}],"display_name_alternatives":["Vicky Cheng"],"block_key":"v cheng","works_api_url":"https://api.openalex.org/works?filter=author.id:A5114085878","updated_date":"2026-11-07T12:08:38","created_date":"2020-05-29T00:00:00"}